May 17, 2022
Owners of Gubra, a founder-owned biotechnology and pre-clinical contract research services organisation ("CRO") and biotechnology firm, are working on a listing or minority sale later this year according to multiple sources, 2020 EBITDA of DKK 32m (NKP Proprietary)
NKP | M&A Insights Proprietary
Headline from pre-deal coverage in M&A Insights